These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 233661)

  • 1. Comparison of the corticotropic action of two synthetic, substituted analogues of ACTH: ACTH1--17 and ACTH1--18.
    Vierhapper H; Waldhäusl W
    J Clin Endocrinol Metab; 1978 Jul; 47(1):208-11. PubMed ID: 233661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corticotropic action of a new, synthetic analogue of ACTH (ACTH1-17) in man after intravenous, intramuscular and intranasal administration (author's transl)].
    Vierhapper H; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jan; 91(2):57-9. PubMed ID: 219629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical responsiveness to the synthetic ACTH 1-17 analogue given at different circadian stages.
    Ferrari E; Bossolo PA; Carnevale Schianca GP; Solerte SB; Fioravanti M; Nascimbene M
    Chronobiologia; 1982; 9(2):133-41. PubMed ID: 6288331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral activity of a short chain ACTH analog.
    Drago F; Continella G; Scapagnini U
    Pharmacol Biochem Behav; 1984 May; 20(5):689-95. PubMed ID: 6330764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effects of an ACTH analogue (ACTH 1-17) on myocardial performance.
    Levi G; Signorini C; Tosoni S; Di Stefano O; Cardone G
    Ric Clin Lab; 1985; 15(4):349-56. PubMed ID: 3010434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropic action of an intra-nasally applied synthetic ACTH derivative.
    Baumann G; Walser A; Desaulles PA; Paesi FJ; Geller L
    J Clin Endocrinol Metab; 1976 Jan; 42(1):60-3. PubMed ID: 175085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against a self-inhibition of ACTH secretion in man.
    Cavagnini F; Invitti C; Danesi L; Passamonti M; Fossati R
    Neuroendocrinology; 1985 Dec; 41(6):518-25. PubMed ID: 3001562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological properties of a biotinylated derivative of ACTH1-17 for MSH receptor studies.
    Bagutti C; Eberle AN
    J Recept Res; 1993; 13(1-4):229-44. PubMed ID: 8383754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of exogenous oxytocin on plasma cortisol in normal human subjects: evidence of action at the adrenal level.
    Legros JJ; Chiodera P; Geenen V
    Neuroendocrinology; 1988 Aug; 48(2):204-6. PubMed ID: 2851753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site.
    Saez JM; Dazord A; Gallet D
    J Clin Invest; 1975 Sep; 56(3):536-47. PubMed ID: 169292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone in relation to interrenal function during stress in tilapia (Oreochromis mossambicus).
    Balm PH; Pepels P; Helfrich S; Hovens ML; Bonga SE
    Gen Comp Endocrinol; 1994 Dec; 96(3):347-60. PubMed ID: 7883141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterase activity of synthetic fragments of human adrenocorticotrophic hormone.
    Eklund KK; Vainio P; Virtanen JA; Kinnunen PK
    Biochem Biophys Res Commun; 1991 May; 177(1):235-42. PubMed ID: 1645957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Alexander AN; Island DP; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corticotropic action of a synthetic analog of ACTH (D-Ser 1, Lys 17, Lys-NH2 18) in man].
    Pizarro M; Kolanowski J; Crabbé J
    Ann Endocrinol (Paris); 1976; 37(5):403-4. PubMed ID: 190942
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of lymphokine (gamma-interferon) production by corticotropin.
    Johnson HM; Torres BA; Smith EM; Dion LD; Blalock JE
    J Immunol; 1984 Jan; 132(1):246-50. PubMed ID: 6317743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropin(1-10) and -(11-24) promote adrenal steroidogenesis by different mechanisms.
    Li ZG; Park D; LaBella FS
    Endocrinology; 1989 Aug; 125(2):592-6. PubMed ID: 2546738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of modulation of the adrenocortical response to ACTH by an opioid peptide.
    Howlett TA; Grossman A; Froud A; Perry L; Besser GM
    Horm Metab Res; 1991 Jul; 23(7):341-3. PubMed ID: 1663480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER
    J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between adrenal steroid secretion after stimulation with two synthetic analogues of corticotropin : ACTH 1-24 and ACTH 1-17.
    Massucchetti C; Biffignandi P; Gentile L; Molinatti GM
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1423-8. PubMed ID: 6318782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged corticotropic action of synthetic human ACTH in man.
    Baumann G; Felber JP
    J Clin Endocrinol Metab; 1976 Jan; 42(1):160-3. PubMed ID: 175083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.